StockNews.com Upgrades Iradimed (NASDAQ:IRMD) to “Strong-Buy”
Iradimed (NASDAQ:IRMD – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Friday. Separately, Roth Mkm restated a “buy” rating and issued a $72.00 price target (up previously from $60.00) on shares of Iradimed in a research note on […]
Iradimed (NASDAQ:IRMD – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Friday. Separately, Roth Mkm restated a “buy” rating and issued a $72.00 price target (up previously from $60.00) on shares of Iradimed in a research note on […]
